Evaluation of a disease-state education program in asthma: Application of the Knowledge-to-Action Framework.

IF 2.6 3区 医学 Q2 ALLERGY
Allergy and asthma proceedings Pub Date : 2025-03-01 Epub Date: 2025-01-27 DOI:10.2500/aap.2025.46.240112
Nazrin Yusufova, Ileen A Gilbert, Frank Trudo, Theodore Barlows, Scott Salvato, Omar Motawakel, James M Eudicone, Kevin R Murphy
{"title":"Evaluation of a disease-state education program in asthma: Application of the Knowledge-to-Action Framework.","authors":"Nazrin Yusufova, Ileen A Gilbert, Frank Trudo, Theodore Barlows, Scott Salvato, Omar Motawakel, James M Eudicone, Kevin R Murphy","doi":"10.2500/aap.2025.46.240112","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> In patients with asthma, bronchoconstriction and airway inflammation both contribute to airway narrowing and airflow limitations, which lead to symptoms and exacerbations. Short-acting β₂-agonist (SABA)-only rescue therapy addresses only bronchoconstriction and is associated with increased morbidity and mortality. Current asthma management guidelines recommend concomitant treatment of symptoms and inflammation with a fast-acting bronchodilator and inhaled corticosteroid (ICS) as rescue therapy for patients ≥12 years of age. However, there is an education and outreach gap for the wider adoption of anti-inflammatory rescue therapy in clinical practice. <b>Objective:</b> AstraZeneca has developed an education program for health-care practitioners (HCPs) based on a Knowledge-to-Action Framework, with the aim of increasing HCPs' understanding of key disease-state concepts related to evidence-based management of asthma. <b>Methods:</b> A multichannel, evidence-based education program was presented at medical conferences across the United States between December 2022 and December 2023. Before and after each event, attendees were asked to complete a survey that rated their agreement with six disease-state concepts on a five-point Likert scale. These concepts related to the role of airway inflammation, fluctuations in inflammation, SABA and ICS therapy, and the risk of exacerbations. Postevent responses to the survey were assessed relative to pre-event responses and longitudinally over 12 months by using calculated odds ratios and 95% confidence intervals. Acceptance and/or understanding of a concept was defined as a rating of \"agree\" or \"strongly agree\" from at least 80% of respondents. <b>Results:</b> The proportion of respondents who agreed or strongly agreed with each concept was significantly higher postevent versus pre-event (p < 0.001). The 80% acceptance and/or understanding threshold was surpassed for all concepts after the event. <b>Conclusion:</b> The medical education program improved understanding and/or acceptance of key disease-state concepts related to asthma management among participating HCPs. Effective communication of disease management concepts may lead to improved patient health outcomes through more rapid acceptance of guideline-recommended medical therapies.</p>","PeriodicalId":7646,"journal":{"name":"Allergy and asthma proceedings","volume":" ","pages":"126-134"},"PeriodicalIF":2.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy and asthma proceedings","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2500/aap.2025.46.240112","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In patients with asthma, bronchoconstriction and airway inflammation both contribute to airway narrowing and airflow limitations, which lead to symptoms and exacerbations. Short-acting β₂-agonist (SABA)-only rescue therapy addresses only bronchoconstriction and is associated with increased morbidity and mortality. Current asthma management guidelines recommend concomitant treatment of symptoms and inflammation with a fast-acting bronchodilator and inhaled corticosteroid (ICS) as rescue therapy for patients ≥12 years of age. However, there is an education and outreach gap for the wider adoption of anti-inflammatory rescue therapy in clinical practice. Objective: AstraZeneca has developed an education program for health-care practitioners (HCPs) based on a Knowledge-to-Action Framework, with the aim of increasing HCPs' understanding of key disease-state concepts related to evidence-based management of asthma. Methods: A multichannel, evidence-based education program was presented at medical conferences across the United States between December 2022 and December 2023. Before and after each event, attendees were asked to complete a survey that rated their agreement with six disease-state concepts on a five-point Likert scale. These concepts related to the role of airway inflammation, fluctuations in inflammation, SABA and ICS therapy, and the risk of exacerbations. Postevent responses to the survey were assessed relative to pre-event responses and longitudinally over 12 months by using calculated odds ratios and 95% confidence intervals. Acceptance and/or understanding of a concept was defined as a rating of "agree" or "strongly agree" from at least 80% of respondents. Results: The proportion of respondents who agreed or strongly agreed with each concept was significantly higher postevent versus pre-event (p < 0.001). The 80% acceptance and/or understanding threshold was surpassed for all concepts after the event. Conclusion: The medical education program improved understanding and/or acceptance of key disease-state concepts related to asthma management among participating HCPs. Effective communication of disease management concepts may lead to improved patient health outcomes through more rapid acceptance of guideline-recommended medical therapies.

哮喘疾病状态教育计划的评估:知识到行动框架的应用。
背景:在哮喘患者中,支气管收缩和气道炎症均可导致气道狭窄和气流受限,从而导致症状和加重。仅使用短效β 2激动剂(SABA)的抢救治疗仅针对支气管收缩,且与发病率和死亡率增加有关。目前的哮喘管理指南建议将症状和炎症的同时治疗与速效支气管扩张剂和吸入皮质类固醇(ICS)作为12岁患者的抢救治疗。然而,在临床实践中广泛采用抗炎救援治疗存在教育和推广差距。目的:阿斯利康根据“从知识到行动框架”为卫生保健从业人员(HCPs)制定了一项教育计划,旨在提高HCPs对哮喘循证管理相关关键疾病状态概念的理解。方法:在2022年12月至2023年12月期间,在美国各地的医学会议上提出了一项多渠道、循证教育计划。在每次活动之前和之后,参与者被要求完成一项调查,以五分制的李克特量表对他们对六种疾病状态概念的认同程度进行评分。这些概念与气道炎症的作用、炎症的波动、SABA和ICS治疗以及恶化的风险有关。通过计算的优势比和95%置信区间,对调查的事后反应相对于事前反应和纵向12个月进行评估。接受和/或理解一个概念被定义为至少80%的受访者的“同意”或“非常同意”评级。结果:同意或强烈同意每个概念的受访者比例在事件发生后明显高于事件发生前(p < 0.001)。事件发生后,所有概念都超过了80%的接受和/或理解阈值。结论:医学教育计划提高了参与的医护人员对哮喘管理相关的关键疾病状态概念的理解和/或接受程度。疾病管理概念的有效沟通可以通过更快速地接受指南推荐的医学治疗来改善患者的健康结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
35.70%
发文量
106
审稿时长
6-12 weeks
期刊介绍: Allergy & Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists. The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma. Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信